Thus, the aim of this work was to assess the induction of selective autophagy via Ezrin inhibition as pharmacological therapy to rescue PRs' cell death from RHOP23H accumulation and cellular stress at the onset of molecular and clinical symptoms of retinal degeneration; thus, in turn, blocking the transition of cell fate from survival to death. Here, EZR is linked to retinal degeneration.